AI-guided microneedles bend at body temperature to speed diabetic wound healing

Chronic wounds remain a major health care challenge, especially for people with diabetes, who often experience delayed ...

A Gene-Therapy Pioneer Just Filed For Chapter 11 Bankruptcy—Now Eli Lilly Wants Its Tech

A California gene-therapy pioneer has filed for bankruptcy. Eli Lilly and Astellas have already lined up bids to buy pieces ...
Deccan Chronicle

Chennai: For All FTA Talks, There Should Be A Model Pharma Chapter: Niti Aayog

The Mission Biopharma SHAKTI scheme, launched in 2026-27, marks an important step in promoting biologics and biosimilars ...
The Pharma Letter

Sangamo files for bankruptcy as Lilly and Astellas target assets

US genomic medicine company Sangamo Therapeutics has filed for Chapter 11 bankruptcy protection as it prepares to auction off ...

Sangamo Therapeutics Initiates Chapter 11 and Asset Sales

Detailed price information for Sangamo Therapeutics Inc (SGMO) from The Globe and Mail including charting and trades.
GEN - Genetic Engineering and Biotechnology News

Gene Editing Pioneer Sangamo Files for Chapter 11 Bankruptcy; Agrees to Sell Assets

Sangamo Therapeutics, a pioneering gene editing biotech company in the Bay Area, has filed for Chapter 11 bankruptcy protection and agreed to sell some of its programs and platforms to Eli Lilly and ...